Detalhe da pesquisa
1.
Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.
J Infect Dis
; 222(3): 381-390, 2020 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31714954
2.
Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.
Front Immunol
; 14: 1113194, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36999017
3.
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
Hum Vaccin Immunother
; 19(2): 2240690, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37553178
4.
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy.
Front Immunol
; 14: 1183983, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37205095
5.
Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens.
Front Immunol
; 14: 1148877, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37153598
6.
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trials.
Trials
; 24(1): 465, 2023 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37480110
7.
Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
PLoS One
; 17(11): e0275927, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36327320